Centea Scott
- SEC CIK
- 0001823973
No open-market purchases or sales filed in the past year.
Current role at each company
- ANGO Angiodynamics IncSVP/GM, VITas of Sep 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Centea Scott as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 18, 2021 (view filing) | Oct 15 | 3 days | Centea ScottSr. VP/GM, Global VIT | SSale | −12.0K | $27.92 | −$335.0K | −20.6%46.2K after |